Data privacy especially when health data are involved and therefore coding, anonymization, and pseudo-anonymization are a very sensitive topic in clinical trials, whether interventional or not.
The Italian DPA found that the data were not anonymous: the assigned identifier combined with detailed information such as year of birth, sex, and diagnoses, made it possible to re-identify patients.